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The Global Partnership for Effective Diabetes Management has previously recommended the implementa-
tion of an interdisciplinary team (IDT) approach to type 2 diabetes (T2DM) management as one of 10
practical steps for health care professionals to help more people achieve their glycaemic goal. This article
discusses some of the key contributors to success and also the challenges faced when applying IDT care,
by examining case studies and examples from around the world. The real-world practices discussed show
that implementing successful interdisciplinary care in diabetes is possible despite significant barriers
such as established hierarchal structures and financial resource constraints. Instituting collaborative,
integrated working relationships among multiple disciplines under strong leadership, together with
enhanced and active communication and improved patient access to appropriate specialties is essential.
Patients have a crucial role in the management of their own disease and including them as part of the
treatment team is also critical. IDTs in diabetes care improve patient outcomes in terms of control of gly-
caemia and cardiometabolic risk factors, and decreased risk of diabetes complications. Ensuring access to
an appropriate IDT, in whatever form, is paramount to enable the best care to be delivered.
 2016 The Authors. Published by Elsevier Inc. This is an open access article under theCCBY-NC-ND license
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In 2007, the Global Partnership for Effective Diabetes Management
recommended the implementation of an interdisciplinary team
(IDT) approach to type 2 diabetes (T2DM) management [1] as
one of 10 practical steps for health care professionals (HCPs) to
help more people achieve their glycaemic goal [2]. IDT approaches
to diabetes care provision have previously been reported to pro-
vide the greatest positive impact on glycaemic control in people
with T2DM [3]. In this article, the Global Partnership discusses some
of the key contributors to success and also the challenges faced
when implementing IDT care, by examining case studies and
examples from around the world reflecting circumstances that
have varying degrees of resource availability or other constraints.Real-world experiences of IDTs in practice
Effective IDT models in the real-world setting offer examples of
best practice and effective frameworks that can be applied to pro-
vide innovative solutions to the challenges of establishing team-
based diabetes care. Examples of such frameworks from different
locations and in environments with widely varying resources are
outlined here to illustrate how IDT approaches can be established
in practice, and highlight common themes that arise.USA: An IDT approach in an integrated health care delivery system
The Ochsner Medical Center’s ‘Diabetes Empowerment Clinic’ is a
pilot initiative aimed at improving patient access to specialist care
at Ochsner Health System primary care clinics in South East Louisi-
ana. This initiative creates clinical teams with shared goals that
deliver parallel and coordinated management strategies in a
patient-centred format. The predecessor to the Diabetes Empower-
ment Clinic was Boot Camp, which was conducted within the pri-
mary care department and involved a primary care trained nurse
practitioner, endocrinology-certified diabetes educator (CDE) and
a pharmacist. However, the scope of this programme was limited
to a one-time intensive visit designed to initiate treatment, which
was then followed-up by a primary care physician (PCP). The suc-
cess of Boot Camp led to the creation of the Diabetes Empowerment
Clinic where initial and 3 to 6-month follow-up care is provided by
an integrated IDT comprised of a diabetes trained nurse practi-
tioner, a CDE, endocrinologists and at times a pharmacist.
Patients are initially referred by a PCP for an assessment with a
CDE who then triages them to the Diabetes Empowerment Clinic
unless they met criteria to have their care assumed by a diabetes
nurse practitioner in the Endocrinology Department. The criteria
include type 1 diabetes (T1DM), T2DMwith poor glycaemic control
on multiple daily injection therapy or an insulin pump, patients
requiring U 500 insulin, or urgent or marked hyperglycaemia.
The Diabetes Empowerment Clinic provides patients with individu-
alized diabetes education and a management plan delivered
through an IDT, until the patient’s HbA1c improves to their individ-
ualized target (typically 2–3 visits). Participation in the Diabetes
Empowerment Clinic also provides patients with the option of see-
ing, or obtaining referrals to, other Ochsner Medical Centre special-
ists. At the conclusion of the Diabetes Empowerment Clinic, patients
are transitioned back to the care of their PCPs along with clear
communication of their individual goals, results and barriers to
care. Some patients, when deemed appropriate, will be referred
to the Endocrinology Department for longer term diabetes care.
Exposure to Boot Camp resulted in a substantial reduction in
HbA1c levels in patients with poorly-controlled diabetes (HbA1c
declined from 11.02% to 8.24% [96.94 mmol/mol to 66.56 mmol/
mol] for Boot Camp participants vs. 10.89% to 10.16%[95.53 mmol/mol–87.55 mmol/mol] for those not enrolled in Boot
Camp). In the Diabetes Empowerment Clinic pilot of 124 patients
completing the programme, the mean HbA1c at entry was 9.74%
(82.96 mmol/mol; SD 1.92) and at completion the mean HbA1c
was 6.75% (50.28 mmol/mol; SD 0.75). 94% of the patients that
completed the programme met the Healthcare Effectiveness Data
and Information Set (HEDIS) goal of HbA1c <8% (63.94 mmol/mol)
and 68% achieved a HbA1c of <7% (53.01 mmol/mol). These initia-
tives, including the less complex Boot Camp, show that improved
integrated care can provide real benefits for patients, including
improved glycaemic control.Hong Kong: Structured IDT approach implemented on a large scale in
the public sector
Hong Kong has a heavily-subsidized health care system, with
most chronic care provided in public hospitals and clinics. In
1995, the Chinese University of Hong Kong and Prince of Wales
Hospital jointly initiated a quality improvement programme for
diabetes care. This comprised a nurse-coordinated comprehensive
assessment programme that used structured protocols to establish
the Hong Kong Diabetes Registry, followed by group empowerment
and IDT care.
The implementation of this diabetes complications screening
programme led to the creation of the diabetes nurse specialist role
and hospital-based Diabetes Centres, which coordinate diabetes
care and the empowerment programme. The documentation of
risk factors, complications and clinical outcomes enabled the IDT
to develop and validate a series of risk equations, and in 2007
the integrated care model was digitalized to form the web-based
Joint Asia Diabetes Evaluation (JADE) Programme [4] (Fig. 1).
In 2009, the model was adapted and widely implemented to
become the Multidisciplinary Risk Assessment and Management
programme for people with diabetes mellitus (‘RAMP-DM’). This
programme, which operates in public general out-patient clinics
(GOPCs) in Hong Kong, involves patients undergoing a comprehen-
sive risk assessment by a specialist nurse, followed by risk stratifi-
cation and education provided by an IDT [5]. Low-risk patients
continue with the usual follow-up provided by the GOPC,
medium-risk patients are given additional intervention by an
advanced practice nurse (APN), and high-risk/very high risk
patients are given additional intervention by an APN and an asso-
ciate consultant, who is a specialist family physician [5].
At 12 months into the programme, a random sample of 1248
people with T2DM enrolled to RAMP-DM was selected and 1248
people with diabetes under usual primary care were matched by
age, sex, and HbA1c level at baseline [6]. Compared with the usual
care group, the RAMP-DM group with risk-stratification and IDT
had a lower incidence of cardiovascular events (1.21% vs. 2.89%,
p = 0.003), and a net decrease in HbA1c (0.20%, p < 0.01), systolic
blood pressure (3.62 mmHg, p < 0.01) and 10-year estimated
risks of cardiovascular disease (CVD) (total CVD risk, 2.06%,
p < 0.01; coronary heart disease risk, 1.43%, p < 0.01; and stroke
risk, 0.71%, p < 0.01) [6]. A significant increase in the proportion
of patients reaching treatment targets of HbA1c and blood pressure
was also observed in the RAMP-DM group [6]. In a subsequent 3-
year analysis, the RAMP-DM group had lower incidences of individ-
ual and total cardiovascular complications, as well as all-cause
mortality, compared with the usual care group [7].
RAMP-DM is an example of a programme run on a large scale in
a public sector where variations between clinics occur. Its success
lies in ensuring that clinics maintain the core operation framework
with minimal modifications to the protocol [5]. Frequent site visits
to the clinics by the governing body also enables issues to be iden-
tified and addressed appropriately [5].
Fig. 2. The ‘Leicester model’ – primary care clinic categories. ‘Super six’ – patients on insulin pumps, those with antenatal diabetes, patients requiring diabetic foot care or
with low estimated glomerular filtration rate who need dialysis, patients with uncontrolled type 1 diabetes/adolescent diabetes, and people with diabetes who are inpatients
[9].
Fig. 1. The integrated diabetes care model at the Chinese University of Hong Kong and Prince of Wales Hospital using the web-based Joint Asia Diabetes Evaluation (JADE)
Programme. *The JADE Programme provided the premise for the implementation of the territory-wide Risk Assessment Management Progamme in diabetes mellitus (RAMP-
DM) in the community-based clinics coordinated by nurse specialists and general practitioners.
M. McGill et al. / Journal of Clinical & Translational Endocrinology 7 (2017) 21–27 23
Successful 
interdisciplinary 
team  
Working 
collaboravely 
to foster 
supporve 
relaonships
Strong and 
commied 
organizaonal 
and team 
leadership 
Diversity in 
experse, with 
team members 
tailored to local 
circumstances
Shared goals 
and approaches 
to ensure 
consistency of 
message 
Clear and open 
communicaon 
within the team 
and with 
paents 
The paent at 
the centre of 
decision-making  
Fig. 3. Key contributors to a successful IDT in diabetes care.
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model
A model implemented in the UK transitions people with less
complex diabetes to primary care while specialists manage the
treatment of six categories of patients termed the ‘super six’ –
patients on insulin pumps, those with antenatal diabetes, patients
requiring diabetic foot care or with low estimated glomerular fil-
tration rate who need dialysis, patients with uncontrolled T1DM/
adolescent diabetes, and people with diabetes who are inpatients
[8]. However, some aspects of diabetes care still require coopera-
tion between specialists and PCPs [8], and as a result a collabora-
tive relationship was established whereby specialists and PCPs
maintained regular communication. Specialists also undertook
annual/biannual visits to the primary care clinic to discuss com-
plex cases with their primary care colleagues.
In the city of Leicester, this model was expanded further within
the primary care setting by dividing clinics into different tiers to
provide enhanced services where applicable (Fig. 2). A patient edu-
cation programme (DESMOND, Diabetes Education and Self-
Management for Ongoing and Newly Diagnosed) was incorporated
in clinics within Tiers 1 and 2, while Tiers 3a and 3b were under-
pinned by more integrated care with additional team members
or services. Tier 3a clinics provide the ‘necessary nine’ services
(Fig. 2), which enabled them to manage even more complex
patients. To date, this system has proven to be cost-effective, with
no increase in the death rate or hospitalizations.Mexico: IDT diabetes care in a resource-poor environment
With 75% of people with diabetes living in low- and middle
income countries [8], there is a pressing need for innovative
cost-effective methods to enable the best possible diabetes care.
In Mexico, government health centres are overcrowded and limited
to non-specialist care, while private care is expensive with frag-
mented access to services. The Clínicas del Azúcar was created to
provide a community-based medical service for diabetes patients,
facilitated by an IDT composed of physicians, nurse practitioners,
dietitians, psychologists, physical trainers, sociologists and labora-
tory technicians.
The critical aspect of Clínicas del Azúcar was providing access to
specialized diabetes care for large numbers of people regardless of
an individual’s economic status. This was achieved through offer-
ing a single fixed-fee annual payment (approximately US $250)
that provided coverage for unlimited medical consultation, nutri-
tional management, counseling, diabetes education, physical activ-
ity counseling, laboratory tests, and screening/examinations for
detection of chronic complications. Through the work of the clinics,
treatment outcomes have improved, and significant reductions in
costs have been achieved.The impact of an IDT in T2DM
The IDT approach can be effective in delivering care to people
who have chronic conditions, such as T2DM, that require both
self-management and major lifestyle alterations. In the case of
T2DM, the complexity of the disease and its associated multiple
comorbidities also raises particular diverse challenges that individ-
ual clinicians may find difficult to manage. Integrated team-based
care has been associated with improved glycaemic control and
reduced HbA1c levels in people with diabetes [10–14]. For exam-
ple, a 6-month, randomized, controlled trial of individuals with
poorly controlled diabetes showed that a management programme
delivered by a nurse-led IDT (including a diabetes nurse educator,
psychologist, pharmacist and nutritionist) significantly reducedHbA1c levels compared with usual diabetes care provided by PCPs
(1.3% vs. 0.2%, respectively, p < 0.0001) [14].
An IDT approach also has further benefits in terms of blood
pressure [10,15] and lipid level reductions [10], as well as improve-
ments in quality of life [12,13]. In addition, IDT care involving a
variety of HCPs, such as nurses, podiatrists and endocrinologists,
has been shown to reduce the risk of amputation at the lower
extremity by 34–47% [16–19]. Furthermore, IDT care is associated
with a significantly reduced risk of end-stage renal disease in
patients with T2DM nephropathy [20,21], and significantly reduces
the risk of mortality compared with non-integrated care [22].Key contributors to an effective IDT
Although the IDT approach has gained presence globally in
T2DM management, the factors that contribute to its effective
implementation are not widely understood, and differ depending
on available resources and local working practices. There are, how-
ever, some key contributors to establishing a successful IDT
approach to diabetes care delivery, which are outlined here (Fig. 3).
A key function of an IDT is providing continuous, accessible,
consistent and effective care focused on an individual patient’s
needs and goals. Within the team itself, a fundamental principle
of an IDT is equality and interdependence between team members
[1]. In particular, the focus is on how various specialists in the team
function together in an integrated manner (interdisciplinary)
rather than alongside each other (multidisciplinary), and how flex-
ibility is needed with respect to professional boundaries [1]. It is
critical to identify shared core roles and responsibilities while dif-
ferentiating these from the unique contribution of each specialty.
Working as a team requires members to be willing and committed
to working collaboratively to create an environment that fosters
trust and cultivates supportive relationships. A work setting that
encourages mentoring, and ensures achievements and contribu-
tions are recognized further facilitates a successful partnership
between team members.
Fig. 4. Royal Prince Alfred Hospital: an inter-disciplinary diabetes centre⁄ (education is integrated with clinical service and care is shared with primary care.). *Established in
1985. CGM, continuous glucose monitoring; GDM, gestational diabetes mellitus.
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that is committed to the IDT approach [23]. This is also necessary
at a team level, in which leadership, whether by physicians, phar-
macists or specialist nurses, has been recognized as an essential
element in successful IDT delivery [24]. Individuals who are lead-
ing the team should be clear on when and how to be a team player.
Creativity and adaptability within the team should be encouraged
given that an IDT approach can vary depending on factors such as
number of patients involved and resource constraints. It is also
important that all members of the team have a voice, no matter
how junior or inexperienced. While seniority should be respected,
junior members of staff often have innovative and creative ideas
that deserve to be heard. In this way, inclusivity within the team
is encouraged and job satisfaction improved.
A diverse team of HCPs with complementary expertise is con-
sistently recommended across IDT practical guidelines [1,23] and
such an approach can be seen in practice (see Fig. 4 for an example
of an inter-disciplinary diabetes centre at Royal Prince Alfred
Hospital, Sydney, Australia). The Global Partnership has previously
suggested team composition should be tailored to local needs,
available resources and clinical setting [1,23], and also suggests
that a ‘team’ can be composed of an individual patient and a HCP
as long as best practice principles are applied.
Having a shared goal and approach within the IDT is critical
[1,23] and such alignment within the team facilitates the delivery
of clear and consistent messages to people with diabetes. This also
contributes to the process of developing coordinated management
plans that have the patient as the focus of decision-making [1,25].
Part of ensuring adequate implementation of shared approaches is
clear and open communication [1]. Embedding communication
strategies into the team’s routine helps to create the framework
and opportunity for effective and timely team interactions [23].
For example, regular and structured review meetings designed to
develop an agreed approach, and daily team case conferences
where patient’s medical records are reviewed.
As with all health care providers, continued professional train-
ing is essential for all IDT members who should possess at least a
competent level of knowledge of diabetes and diabetes therapies,
and keep up-to-date with advances in the field that might affect
day-to-day patient management. The ability to impart knowledge
of diabetes and its complications, and inform patients of how bestto self-manage is a fundamental function of a diabetes IDT. More-
over, team members with different skill sets tend to educate and
inform each other, which leads to a broader understanding of dia-
betes management that can further enhance patient care.
Given the pluralistic needs of an individual with T2DM – and
that those needs vary during the clinical course of a few decades
– a structured, coordinated and integrated care programme will
help to ensure that the appropriate treatment (e.g. specialist, pri-
mary, paramedical care) or intervention (e.g. education, peer sup-
port) is provided at the right time and in the correct setting [4].
In areas with limited resources or capacity, diabetologists are often
required to take on the combined role of being a manager, a men-
tor and a monitor to enable their expertise to benefit patients
through other team members.
A further consideration is the silent nature of many diabetes
risk factors and complications. Most professional bodies recom-
mend regular comprehensive assessment to enable early detection
and personalized intervention (taking risks and benefits into con-
sideration) [26,27]. Using protocols and through task delegation,
effective implementation of comprehensive assessment pro-
grammes, followed by data management for risk stratification
and care triage, is one possible way to deliver personalized care
effectively and efficiently with quality assurance [28,29]. In the
chronic care model, documentation is a fundamental aspect of care
provision; in the absence of patient records being kept or main-
tained, continuity of care becomes almost impossible.The challenges
Implementation of an IDT approach is not without its
challenges, and due to the increasing prevalence of T2DM, new
models of care need to be analyzed and tested [30,31]. With
equality and interdependence as a key principle, the traditional
hierarchal structure that exists in many institutions can act as a
barrier to effective IDT care. Other major challenges include a lack
of resources to establish an IDT, inadequate access to appropriate
specialties, time-poor working environments, and poor communi-
cation within the team and with patients [25,32]. Organizational
factors, such as individual work schedules, can prevent
regular communication among team members [25], resulting in
26 M. McGill et al. / Journal of Clinical & Translational Endocrinology 7 (2017) 21–27misalignment of treatment goals and poorer patient outcomes
[25].
In many countries/areas, acute hospital and episodic primary
care are the traditional modes of care delivery. However, for people
with diabetes who need education, empowerment and engage-
ment to understand the nature of the disease and the ‘what, why
and how’ of diabetes self-management, changes of setting and
workflow are required to enable trustworthy relationships to
develop between the patient and the IDT. The establishment of
centres to facilitate IDT care can often achieve these aims and is
also highly conducive to team-building, which promotes mutual
learning and quality improvement.
Conclusions
The real-world examples outlined here show that implement-
ing successful interdisciplinary care in diabetes is possible despite
significant barriers. Overcoming an established hierarchal struc-
ture is challenging and financial resource constraints are perhaps
one of the greatest impediments to the delivery of adequate IDT
care. Moreover, establishing collaborative, integrated working rela-
tionships among multiple disciplines under the direction of strong
leadership (including enhanced and active communication) and
improving patient access to appropriate specialties is essential.
The role of patients in their own disease management is crucial
and it is therefore critical to include them as part of the treatment
team to enable regular communication and share management
goals.
As shown, IDTs in diabetes care contribute to improvements in
treatment outcomes for patients and ensuring access to an appro-
priate IDT, in whatever form, is paramount. Putting in place the key
contributors to an effective IDT within a framework that suits
regional or country-specific circumstances, as highlighted by the
examples provided here, allows the best care to be delivered to
people with diabetes.
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